Literature DB >> 10332866

Improved visualization of the human lung in 1H MRI using multiple inversion recovery for simultaneous suppression of signal contributions from fat and muscle.

V M Mai1, J Knight-Scott, S S Berr.   

Abstract

1H magnetic resonance imaging of the lung is hampered by the low contrast between lung parenchyma, and muscle and fat in the thorax. We show that it is possible to improve contrast greatly and thereby enhance the visibility of the lung, by suppression of signal of surrounding muscle and fat based on differences in T1 relaxation times using a double inversion recovery preparation pulses (TI1 800 msec, and TI2 150 msec) and a half-Fourier acquisition single-shot turbo spin-echo (HASTE) sequence. The measured T1 values for the right and left lungs at 1.5 T were 1.37 +/- 0.18 and 1.41 +/- 0.21 sec, respectively.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10332866     DOI: 10.1002/(sici)1522-2594(199905)41:5<866::aid-mrm2>3.0.co;2-d

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  10 in total

1.  Magnetization transfer short inversion time inversion recovery enhanced 1H MRI of the human lung.

Authors:  Peter M Jakob; Tungte Wang; Georg Schultz; Helge Hebestreit; Alexandra Hebestreit; Marco Elfeber; Dietbert Hahn; Axel Haase
Journal:  MAGMA       Date:  2002-11       Impact factor: 2.310

2.  Long T2 suppression in native lung 3-D imaging using k-space reordered inversion recovery dual-echo ultrashort echo time MRI.

Authors:  Neville D Gai; Ashkan A Malayeri; David A Bluemke
Journal:  MAGMA       Date:  2017-03-10       Impact factor: 2.310

3.  (1)H-MR imaging of the lungs at 3.0 T.

Authors:  Sergei I Obruchkov; Michael D Noseworthy
Journal:  Quant Imaging Med Surg       Date:  2016-02

4.  Ventilation/Perfusion Relationships and Gas Exchange: Measurement Approaches.

Authors:  Susan R Hopkins
Journal:  Compr Physiol       Date:  2020-07-08       Impact factor: 9.090

Review 5.  Multimodality molecular imaging of the lung.

Authors:  Delphine L Chen; Paul E Kinahan
Journal:  J Magn Reson Imaging       Date:  2010-12       Impact factor: 4.813

6.  Lung Parenchymal Signal Intensity in MRI: A Technical Review with Educational Aspirations Regarding Reversible Versus Irreversible Transverse Relaxation Effects in Common Pulse Sequences.

Authors:  Robert Mulkern; Steven Haker; Hatsuho Mamata; Edward Lee; Dimitrios Mitsouras; Koichi Oshio; Mukund Balasubramanian; Hiroto Hatabu
Journal:  Concepts Magn Reson Part A Bridg Educ Res       Date:  2014-03-01       Impact factor: 0.481

7.  Functional lung MRI in chronic obstructive pulmonary disease: comparison of T1 mapping, oxygen-enhanced T1 mapping and dynamic contrast enhanced perfusion.

Authors:  Bertram J Jobst; Simon M F Triphan; Oliver Sedlaczek; Angela Anjorin; Hans Ulrich Kauczor; Jürgen Biederer; Julia Ley-Zaporozhan; Sebastian Ley; Mark O Wielpütz
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

Review 8.  Magnetic resonance angiography for the primary diagnosis of pulmonary embolism: A review from the international workshop for pulmonary functional imaging.

Authors:  Nanae Tsuchiya; Edwin Jr van Beek; Yoshiharu Ohno; Hiroto Hatabu; Hans-Ulrich Kauczor; Andrew Swift; Jens Vogel-Claussen; Jürgen Biederer; James Wild; Mark O Wielpütz; Mark L Schiebler
Journal:  World J Radiol       Date:  2018-06-28

9.  Cardio-Respiratory synchronized bSSFP MRI for high throughput in vivo lung tumour quantification.

Authors:  Ana L Gomes; Paul Kinchesh; Stuart Gilchrist; Philip D Allen; Luiza Madia Lourenço; Anderson J Ryan; Sean C Smart
Journal:  PLoS One       Date:  2019-02-12       Impact factor: 3.240

10.  T1 Relaxation Time in Lungs of Asymptomatic Smokers.

Authors:  Daniel F Alamidi; Simon S I Kindvall; Penny L Hubbard Cristinacce; Deirdre M McGrath; Simon S Young; Josephine H Naish; John C Waterton; Per Wollmer; Sandra Diaz; Marita Olsson; Paul D Hockings; Kerstin M Lagerstrand; Geoffrey J M Parker; Lars E Olsson
Journal:  PLoS One       Date:  2016-03-09       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.